BillionToOne is a molecular counter platform designed to accurately count DNA molecules to the single-count level. With a mission to detect disorders such as cystic fibrosis and sickle-cell disease, the company optimizes the signal-to-noise ratio through blood testing. The platform specializes in both prenatal and oncology divisions. BillionToOne was founded by David Tsao, Oguzhan Atay, and Sukrit Silas in 2016 and is headquartered in San Francisco, CA.

Register for Details

For more details on financing and valuation for BillionToOne, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about BillionToOne

Forge green plus iconForge green minus icon

What is BillionToOne's IPO price?

The IPO price for BillionToOne will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in BillionToOne?

BillionToOne is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell BillionToOne shares pre-IPO?

If you own BillionToOne pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is BillionToOne a publicly traded company?

BillionToOne is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is BillionToOne's funding to date?

BillionToOne has raised $407.89MM to date.
Forge green plus iconForge green minus icon

When was BillionToOne founded?

BillionToOne was founded in 2016.

Who are BillionToOne's major investors?

Y Combinator
Adams Street Partners
Northwest Venture Partners
Hemisphere Ventures
Four Rivers Group
Fifty Years
500 Global
UpHonest Capital
Time BioVentures
Start Capital
Metaplanet Holdings
Neotribe Ventures
HOF Capital
Hummingbird Ventures
U.S. Department of Health and Human Services
Civilization Ventures
NewDo Venture

BillionToOne funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation

Series D

$130.47MM raised $XXX.XX $XXX.XX

Series C-1

$33.87MM raised $XXX.XX $XXX.XX

Series C

$155MM raised $XXX.XX $XXX.XX

Series B-1

$55MM raised $XXX.XX $XXX.XX

Series B-2

$16.02MM raised $XXX.XX $XXX.XX

Series A-6

$15.02MM raised $XXX.XX $XXX.XX

Series A-1, A-2, A-3, A-4 and A-5

$2.5MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jun 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.